NANTONG NOATIC BIO-PHARM TECHNOLOGY CO LTD
Overview
NANTONG NOATIC BIO-PHARM TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering (2R,3R)-3-(2,5-DIFLUOROPHENYL)-3-HYDROXY-2-METHYL-4-(1H-1,2,4-TRIAZOL-1-YL) THIOBUTYRAMIDE; LENACAPAVIR DRUG SUBSTANCE INTERMEDIATE LP-4; LENACAPAVIR DRUG SUBSTANCE INTERMEDIATE LPA; LENACAPAVIR DRUG SUBSTANCE INTERMEDIATE LPB; LENACAPAVIR DRUG SUBSTANCE INTERMEDIATE LPE-5; SEMAGLUTIDE DRUG SUBSTANCE INTERMEDIATE XSC.
API / Drug Master Files
NANTONG NOATIC BIO-PHARM TECHNOLOGY CO LTD holds 7 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- ORFORGLIPRON DRUG SUBSTANCE INTERMEDIATE OGHActive2026-04-29
- SEMAGLUTIDE DRUG SUBSTANCE INTERMEDIATE XSCActive2026-01-14
- LENACAPAVIR DRUG SUBSTANCE INTERMEDIATE LP-4Active2025-11-06
- LENACAPAVIR DRUG SUBSTANCE INTERMEDIATE LPE-5Active2025-10-17
- LENACAPAVIR DRUG SUBSTANCE INTERMEDIATE LPAActive2025-09-22
- LENACAPAVIR DRUG SUBSTANCE INTERMEDIATE LPBActive2025-09-22
- (2R,3R)-3-(2,5-DIFLUOROPHENYL)-3-HYDROXY-2-METHYL-4-(1H-1,2,4-TRIAZOL-1-YL) THIOBUTYRAMIDEActive2024-11-11
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to NANTONG NOATIC BIO-PHARM TECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this NANTONG NOATIC BIO-PHARM TECHNOLOGY CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.